Latest Form 4 insider transactions

Geno J Germano, a Director of Entera Bio Ltd., reported multiple transactions in common stock on August 7, 2026.

Shaun Ellen Zitting, Chief Human Resources Officer of NIQ Global Intelligence plc, reported a transaction in 1,516 shares of common stock on August 6, 2026.

Troy Alstead, a Director of Levi Strauss & Co, reported multiple transactions in common stock on August 5, 2026.

Charles William Griege Jr. and 1 other reported changes in beneficial ownership of GBank Financial Holdings Inc. common stock on August 5, 2026.

Rithm Capital Corp. reported changes in beneficial ownership of Rithm Capital Corp. common stock on August 5, 2026.

Rithm Capital Corp. reported changes in beneficial ownership of Rithm Property Trust Inc. common stock on August 5, 2026.

Chirfi Guindo, EVP, Access, Policy & Comms of Merck & Co., Inc., sold 15,000 shares of common stock on August 6, 2026 for $131.00 per share.

Philip Mccartney, EVP: CHIEF INN,PROD&DSG OFCR of NIKE, Inc., sold 524 shares of common stock on August 5, 2026 for $41.60 per share.

Patrick Hugh Conway, Chief Executive Officer, Optum of Unitedhealth Group Inc, sold 500 shares of common stock on August 5, 2026 for $410.00 per share.

Gabriele M Cerrone, a Director and 10% owner of Tiziana Life Sciences Ltd, purchased 42,357 shares of common stock on July 21, 2026 for $0.99 per share.

Jonathan M. Lyons, Sr. Vice President, CFO of Sotera Health Co, reported a transaction in 11,316 shares of common stock on August 5, 2026.

David C Habiger, a Director of Boston Scientific Corp, purchased 2,100 shares of common stock on August 5, 2026 for $47.59 per share.

Heather L. Hasson, Executive Chairman, a Director and 10% owner of FIGS, Inc., reported a transaction in 30,142 shares of common stock on August 5, 2026.

John P Brancaccio, a Director of OKYO Pharma Ltd, purchased 5,000 shares of common stock on July 21, 2026 for $1.48 per share.

Robert John Dempsey, CHIEF EXECUTIVE OFFICER and a Director of OKYO Pharma Ltd, purchased 15,000 shares of common stock on July 22, 2026 for $1.54 per share.

Gary S Jacob, CHIEF DEVELOPMENT OFFICER and a Director of OKYO Pharma Ltd, purchased 3,500 shares of common stock on July 21, 2026 for $1.40 per share.

Gabriele M Cerrone, a Director and 10% owner of OKYO Pharma Ltd, purchased 22,500 shares of common stock on July 21, 2026 for $1.45 per share.

Gabriele M Cerrone, a Director and 10% owner of OKYO Pharma Ltd, purchased 25,000 shares of common stock on July 20, 2026 for $1.40 per share.

Cynthia Ekberg Tsai, a Director of Ethan Allen Interiors Inc, purchased 1,000 shares of common stock on August 5, 2026 for $24.61 per share.

David Ditillo, Chief Information Officer of Corebridge Financial, Inc., sold 12,414 shares of common stock on August 6, 2026 for $34.00 per share.

Ryan Damon, Chief Legal Officer of Criteo S.A., sold 6,178 shares of common stock on August 6, 2026 for $17.23 per share.

Hill Path D Fund LP and 5 others reported changes in beneficial ownership of Dave & Buster's Entertainment, Inc. common stock on August 5, 2026.

Sarah Oughtred, Chief Financial Officer of FIGS, Inc., reported a transaction in 21,962 shares of common stock on August 5, 2026.

Charles R. Corbin Jr., See Remarks of Hilton Grand Vacations Inc., sold 20,691 shares of common stock on August 6, 2026 for $46.90 per share.

Healthcare Holding B.V. Gilde, a 10% owner of Shoulder Innovations, Inc., sold 9,433 shares of common stock on August 5, 2026.

Michael Grissinger, a Director of Lipocine Inc., received 2,000 shares of common stock on August 3, 2026.

Tara I. Stacom, a Director of Ethan Allen Interiors Inc, received 1,306 shares of common stock on August 5, 2026.

Stephane Bancel, Chief Executive Officer and a Director of Moderna, Inc., sold 499,246 shares of common stock on August 5, 2026.

Michel Brousset, Chief Executive Officer and a Director of Waldencast plc, reported a transaction in 264,294 shares of common stock on July 30, 2026.

Sean P Downes, Executive Chairman and a Director of Universal Insurance Holdings, Inc., sold 20,000 shares of common stock on August 5, 2026 for $44.27 per share.